4.325
price down icon1.00%   -0.045
 
loading
전일 마감가:
$4.37
열려 있는:
$4.35
하루 거래량:
592.63K
Relative Volume:
0.14
시가총액:
$564.43M
수익:
-
순이익/손실:
$-110.78M
주가수익비율:
-4.0421
EPS:
-1.07
순현금흐름:
$-75.59M
1주 성능:
-5.13%
1개월 성능:
-15.17%
6개월 성능:
-45.03%
1년 성능:
+29.14%
1일 변동 폭
Value
$4.315
$4.50
1주일 범위
Value
$4.20
$4.85
52주 변동 폭
Value
$2.81
$9.97

Humacyte Inc Stock (HUMA) Company Profile

Name
명칭
Humacyte Inc
Name
전화
919-313-9633
Name
주소
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Name
직원
185
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
HUMA's Discussions on Twitter

HUMA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
HUMA
Humacyte Inc
4.32 564.43M 0 -110.78M -75.59M -1.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
486.91 125.43B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
713.87 76.60B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
669.12 39.57B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
276.05 35.33B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
122.41 28.08B 3.30B -501.07M 1.03B -2.1146

Humacyte Inc Stock (HUMA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-20 재확인 H.C. Wainwright Buy
2023-12-11 개시 H.C. Wainwright Buy
2023-08-14 업그레이드 Piper Sandler Underweight → Neutral
2023-06-22 개시 Cantor Fitzgerald Overweight
2022-05-16 다운그레이드 Piper Sandler Overweight → Underweight
2021-10-29 개시 Cowen Outperform
2021-09-24 개시 Oppenheimer Outperform
2021-09-22 개시 BTIG Research Buy
2021-09-16 개시 Piper Sandler Overweight
모두보기

Humacyte Inc 주식(HUMA)의 최신 뉴스

pulisher
Feb 04, 2025

Humacyte, Inc. (HUMA) Laps the Stock Market: Here's Why - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Investing in Humacyte Inc (HUMA) Is Getting More Attractive - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Financial Analysis: Humacyte Inc (HUMA)’s Ratios Unveil Key Insights - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Examining Humacyte Inc (HUMA) more closely is necessary - US Post News

Feb 04, 2025
pulisher
Feb 01, 2025

Wealth Effects LLC Buys 57,200 Shares of Humacyte, Inc. (NASDAQ:HUMA) - MarketBeat

Feb 01, 2025
pulisher
Jan 30, 2025

Humacyte (NASDAQ:HUMAW) Trading Down 1% – What’s Next? - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

Why Is Bioengineered Human Tissue-Focused Humacyte Stock Surging On Friday? - AOL

Jan 29, 2025
pulisher
Jan 29, 2025

Humacyte and Pluristyx enhance partnership for diabetes treatment By Investing.com - Investing.com South Africa

Jan 29, 2025
pulisher
Jan 28, 2025

Humacyte, Pluristyx Announce Gene Editing Partnership -January 28, 2025 at 12:05 pm EST - Marketscreener.com

Jan 28, 2025
pulisher
Jan 28, 2025

Humacyte and Pluristyx enhance partnership for diabetes treatment - Investing.com India

Jan 28, 2025
pulisher
Jan 28, 2025

Humacyte and Pluristyx Announces Gene Editing Partnership to Support BioVascular Pancreas (BVP?) Development Using iPSCs - Marketscreener.com

Jan 28, 2025
pulisher
Jan 28, 2025

Humacyte and Pluristyx Announce Gene Editing Partnership to Support BioVascular Pancreas (BVP™) Development Using iPSCs - The Manila Times

Jan 28, 2025
pulisher
Jan 28, 2025

Revolutionary Diabetes Breakthrough: Gene-Edited Cell Technology Could End Daily Insulin Injections - StockTitan

Jan 28, 2025
pulisher
Jan 27, 2025

2 Firms Want To Co-Lead Humacyte Investor Suit - Law360

Jan 27, 2025
pulisher
Jan 26, 2025

Humacyte, Inc. (HUMA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 25, 2025

Humacyte: Upside Potential, But I Will Wait For Revenue Trends - Seeking Alpha

Jan 25, 2025
pulisher
Jan 24, 2025

Cantor Fitzgerald Comments on Humacyte FY2025 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 24, 2025

Humacyte’s (HUMA) “Buy” Rating Reiterated at D. Boral Capital - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

HUMACYTE ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Jan 23, 2025
pulisher
Jan 23, 2025

Humacyte, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before January 17, 2025 to Discuss Your RightsHUMA - ACCESS Newswire

Jan 23, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Estimates Humacyte FY2025 Earnings - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

Humacyte moves to test bioengineered vessel in heart surgery - MSN

Jan 22, 2025
pulisher
Jan 22, 2025

Humacyte moves to test bioengineered vessel in heart surgery By Investing.com - Investing.com Australia

Jan 22, 2025
pulisher
Jan 21, 2025

DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The Law - GlobeNewswire

Jan 21, 2025
pulisher
Jan 21, 2025

DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - GlobeNewswire Inc.

Jan 21, 2025
pulisher
Jan 21, 2025

Humacyte (NASDAQ:HUMA) Given Buy Rating at D. Boral Capital - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting - The Manila Times

Jan 21, 2025
pulisher
Jan 21, 2025

Humacyte Announces Planned IND Filing in 2025 to Support - GlobeNewswire

Jan 21, 2025
pulisher
Jan 20, 2025

Humacyte Sends First Shipment of Human Acellular Vessels to Ukraine as Part of Humanitarian Efforts - Fresenius Medical Care

Jan 20, 2025
pulisher
Jan 20, 2025

11,105 Shares in Humacyte, Inc. (NASDAQ:HUMA) Acquired by Brookstone Capital Management - Defense World

Jan 20, 2025
pulisher
Jan 18, 2025

Humacyte (NASDAQ:HUMA) Stock Price Up 10%Time to Buy? - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Cantor Fitzgerald Boosts Earnings Estimates for Humacyte - Defense World

Jan 18, 2025
pulisher
Jan 18, 2025

Humacyte FY2024 EPS Forecast Raised by Cantor Fitzgerald - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

Humacyte (NASDAQ:HUMA) Stock Price Down 6.4%What's Next? - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Class Action Filed Against Humacyte, Inc. (HUMA)January 17, 2 - GuruFocus.com

Jan 17, 2025
pulisher
Jan 17, 2025

Faruqi & Faruqi Reminds Humacyte Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025HUMA - PR Newswire

Jan 17, 2025
pulisher
Jan 17, 2025

HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Jan 17, 2025
pulisher
Jan 17, 2025

HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, - GlobeNewswire

Jan 17, 2025
pulisher
Jan 17, 2025

HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - GlobeNewswire Inc.

Jan 17, 2025
pulisher
Jan 17, 2025

HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Jan 17, 2025
pulisher
Jan 17, 2025

Faruqi & Faruqi Reminds Humacyte Investors of the Pending - GlobeNewswire

Jan 17, 2025
pulisher
Jan 17, 2025

Cantor Fitzgerald Predicts Higher Earnings for Humacyte - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Levi & Korsinsky Notifies Humacyte, Inc. Investors of a Class Ac - GuruFocus.com

Jan 17, 2025
pulisher
Jan 17, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte - Markets Insider

Jan 17, 2025
pulisher
Jan 17, 2025

2025-01-16 | HUMA LAWSUIT ALERT: Levi & Korsinsky Notifies Humacyte, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | NDAQ:HUMA | Press Release - Stockhouse Publishing

Jan 17, 2025
pulisher
Jan 17, 2025

Humacyte, Inc. Class Action: Levi & Korsinsky Reminds Humacyte, - GuruFocus.com

Jan 17, 2025
pulisher
Jan 16, 2025

Shareholders that lost money on Humacyte, Inc.(HUMA) should - GlobeNewswire

Jan 16, 2025
pulisher
Jan 16, 2025

Humacyte, Inc. (NASDAQ:HUMA) Short Interest Update - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Humacyte, Inc. (HUMA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Jan 16, 2025
pulisher
Jan 16, 2025

HUMA Lawsuit Alert! Class Action Against Humacyte, Inc. - TipRanks

Jan 16, 2025
pulisher
Jan 16, 2025

The Gross Law Firm Notifies Shareholders of Humacyte, Inc.(HUMA) of a Class Action Lawsuit and an Upcoming Deadline - Marketscreener.com

Jan 16, 2025

Humacyte Inc (HUMA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$80.45
price down icon 0.48%
$21.26
price up icon 3.35%
$356.13
price up icon 0.72%
$5.0068
price down icon 1.77%
biotechnology ONC
$228.68
price up icon 2.51%
$121.90
price up icon 3.88%
자본화:     |  볼륨(24시간):